TECH - Bio-Techne Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
219.31
+1.54 (+0.71%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close217.77
Open218.75
Bid219.30 x 800
Ask219.88 x 800
Day's Range218.75 - 221.76
52 Week Range132.75 - 222.87
Volume134,658
Avg. Volume144,679
Market Cap8.358B
Beta (3Y Monthly)1.22
PE Ratio (TTM)91.84
EPS (TTM)2.39
Earnings DateFeb 3, 2020 - Feb 7, 2020
Forward Dividend & Yield1.28 (0.59%)
Ex-Dividend Date2019-11-07
1y Target Est239.00
  • Premium Millennial Generation Portfolio
    Yahoo Finance

    Premium Millennial Generation Portfolio

    There are now more than 80 million Millennials, born between 1982 and 2000 and ranging in age from their early 20s to their late-30s. This generation is the largest in history – bigger than even the Baby Boomers. According to our research, Millennials currently account for 24% of total U.S income – some $2.9 trillion in direct annual purchasing power, mostly representing older Millennials established in their work and families. The intersection of several trends – sustainability, healthier living, and an entrepreneurial spirit – has resulted in the emergence and growth of numerous companies well-suited to the millennial generation. The Argus Millennial Generation portfolio consists of 30 stocks that fit many of these themes.

  • Is Bio-Techne Corporation's (NASDAQ:TECH) CEO Paid Enough Relative To Peers?
    Simply Wall St.

    Is Bio-Techne Corporation's (NASDAQ:TECH) CEO Paid Enough Relative To Peers?

    Chuck Kummeth has been the CEO of Bio-Techne Corporation (NASDAQ:TECH) since 2013. This analysis aims first to...

  • PR Newswire

    Bio-Techne To Present At The 2019 Stifel Healthcare Conference

    MINNEAPOLIS , Nov. 7, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth , President and Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference ...

  • CELG vs. TECH: Which Stock Is the Better Value Option?
    Zacks

    CELG vs. TECH: Which Stock Is the Better Value Option?

    CELG vs. TECH: Which Stock Is the Better Value Option?

  • PR Newswire

    Bio-Techne Licenses aTAG Technology from C4 Therapeutics, Inc.

    MINNEAPOLIS, Nov. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, today announced the signing of an agreement with C4 Therapeutics, Inc. to acquire an exclusive license for the Achilles-TAG (aTAG) degradation platform. The aTAG system is a chemical genetic application of the targeted protein degradation modality, harnessing the ubiquitin-proteasome system to induce selective degradation of specific proteins within a cell. When a protein of interest is fused to the aTAG, treatment with this class of Degrader results in degradation of the aTAG-fusion protein.

  • PR Newswire

    Bio-Techne To Present At The Stephens Nashville Investment Conference

    MINNEAPOLIS , Nov. 5, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel , Chief Financial Officer, will present at the Stephens Nashville Investment Conference on ...

  • Thomson Reuters StreetEvents

    Edited Transcript of TECH earnings conference call or presentation 29-Oct-19 1:00pm GMT

    Q1 2020 Bio-Techne Corp Earnings Call

  • Techne (TECH) Q1 Earnings Lag Estimates
    Zacks

    Techne (TECH) Q1 Earnings Lag Estimates

    Techne (TECH) delivered earnings and revenue surprises of -0.93% and 1.77%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Benzinga

    The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study

    The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 28.) AstraZeneca plc (NYSE: AZN ) ( reported positive ...

  • PR Newswire

    Bio-Techne Declares Dividend

    MINNEAPOLIS , Oct. 29, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September ...

  • PR Newswire

    Bio-Techne Releases First Quarter Fiscal 2020 Results

    MINNEAPOLIS , Oct. 29, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2019 . First Quarter FY2020 Snapshot First ...

  • Bio-Techne will open $40M+ facility in St. Paul
    American City Business Journals

    Bio-Techne will open $40M+ facility in St. Paul

    Bio-Techne bought a building not far from the State Capitol for $3 million and will invest tens of millions more to convert the property into a production facility for gene-therapy ingredients.

  • PR Newswire

    Bio-Techne Announces Investment For New GMP Manufacturing Facility

    MINNEAPOLIS , Oct. 28, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global leader in the development and manufacturing of Good Manufacturing Practices (GMP)-grade raw and ancillary reagents, ...

  • Hedge Funds Have Never Been More Bullish On Bio-Techne Corporation (TECH)
    Insider Monkey

    Hedge Funds Have Never Been More Bullish On Bio-Techne Corporation (TECH)

    A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]

  • PR Newswire

    Medicare Issues Final Local Coverage Decision For Bio-Techne's ExoDx™ Prostate(IntelliScore) Test

    MINNEAPOLIS , Oct. 10, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local ...

  • PR Newswire

    Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results

    MINNEAPOLIS , Oct. 8, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, October 29, 2019 , at 8:00 a.m. CDT to review first ...

  • Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation
    PR Newswire

    Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation

    MINNEAPOLIS , Oct. 7, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, ...

  • Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
    Simply Wall St.

    Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

  • 5 Health Care Stocks Held By Gurus
    GuruFocus.com

    5 Health Care Stocks Held By Gurus

    Bausch Health Companies tops the list Continue reading...

  • GuruFocus.com

    Mairs and Power Growth Fund 2nd-Quarter Shareholder Letter

    Discussion of markets and holdings Continue reading...

  • PR Newswire

    Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility

    MINNEAPOLIS , Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing ...

  • GuruFocus.com

    Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2019

    Bio-Techne Corp (TECH) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. Continue reading...

  • Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years
    Simply Wall St.

    Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years

    Bio-Techne Corporation (NASDAQ:TECH) shareholders have seen the share price descend 11% over the month. But that...

  • 5 Tips for Making Money in Penny Stocks
    InvestorPlace

    5 Tips for Making Money in Penny Stocks

    [Editor's note: This story was previously published in April 2018. It has since been updated and republished.]First, let's get something straight. The definition of penny stocks is entirely subjective. What I think constitutes a risky penny stock, you might feel is a robust, thriving enterprise. Therefore, before I answer the question of whether you can make money in penny stocks, I'm going to explain what I believe is the best definition of a penny stock. From there, I'll tackle the five rules investors should follow to be successful in trading penny stocks.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe Definition: Merriam-Webster defines penny stock as "a usually unlisted highly speculative stock usually selling for a dollar or less." Hence, the penny-stock moniker. Others are more liberal in their interpretation of what constitutes a penny stock.The Successful Investor, an investment newsletter publisher I do some work for here in Canada, suggests the ceiling price can go as high as $5. * 7 Retail Stocks to Buy on the Dip Here's what the SEC has to say about penny stocks:"The term 'penny stock' generally refers to a security issued by a very small company that trades at less than $5 per share," states the SEC website. "Penny stocks generally are quoted over-the-counter, such as on the OTC Bulletin Board; penny stocks may, however, also trade on securities exchanges, including foreign securities exchanges."So, I've got reputable sources from both the U.S. and Canada who accurately define what penny stocks are, including the price at which they trade.At $5 or less, I do believe you can make money in stocks, but it helps if you follow these five simple rules.For every success story like Monster Beverage (NASDAQ:MNST), which traded below $5 as recently as 2006, there are hundreds of penny stock failures littered along the investment highway. * The Elite 8 Stocks to Buy for Massive Outperformance Treat penny stocks just as you would any other publicly traded investment, and your chances for success increase exponentially. Tip 1: Buy Companies With Strong Balance SheetsSource: Shutterstock Like any equity investment, it's important that you establish the financial strength of the company. When I look for stocks to invest in whether the share price is $5 or $500, I focus on companies with strong balance sheets. Although no debt is desirable when interest rates are rising, it's not very practical. This is especially true when it comes to penny stocks, many of which are still in the early stages of development. Here are two rules:1\. Only invest in companies whose long-term debt (LTD) is 50% of shareholder equity or less. If a company has $1 million in debt, its shareholder equity should be at least $2 million. 2\. Try to keep your penny-stock bets to those companies whose LTD is less than its market cap; the lower, the better. Tip 2: Buy Profitable CompaniesSource: (C)iStock.com/graphicnoi As with any equity investment, it's important that you limit your investments to profitable businesses. There are two schools of thought on this. On the one hand, investing in publicly-traded companies, whether they're penny stocks or not, provides you with greater liquidity than private investments. Therefore, the ability to exit quicker justifies the higher risk many in this arena are willing to accept to generate outsize future gains. On the other hand, private investments have longer holding periods built into them -- often 3-5 years or more -- which means investors aren't nearly as concerned about profitability as they are with growth. * 10 Marijuana Stocks That Could See 100% Gains, If Not More It really comes down to your ability to handle uncertainty. For me, I'm always looking for companies making money in the here and now. Anything less is called speculation, and while there's nothing wrong with this approach, it's not something novice investors ought to consider. Tip 3: Understand the BusinessSource: Shutterstock Like any equity investment, it's important that you understand the businesses you invest in. There's a saying that if you can't explain what a company's business does in a sentence or two, you probably shouldn't be investing.Imagine you're explaining the investment to your child who attends elementary school. It's easy to describe what Coca-Cola (NYSE:KO) does: it makes soda pop. It's not nearly as simple to describe what business Bio-Techne (NASDAQ:TECH) is in.At least it's not for me. Stick to what you know and understand. That's especially true with penny stocks with smaller market caps. Tip 4: Diversify Source: Simon Cunningham via FlickrLike any equity investment, it's important that you diversify your penny stocks. How many penny stocks should you own? That's the million-dollar question, no matter how big or small the investment. Some professional investors believe you've got to have a concentrated portfolio of your best ideas -- say 10 to 20 -- while others think you should spread your bets far wider over 100 stocks or more. It's a subjective answer for sure. * 10 Undervalued Stocks With Breakout Potential What I do know is that you want to be in at least three or four sectors of the economy that generally are healthy and growing.Since the risk/reward ratio of penny stocks can be significantly higher than that of large-cap stocks such as Coca-Cola, it's far more important to diversify your investments. Tip 5: Risk What You Can Afford to LoseSource: Shutterstock Like any equity investment, it's important that you understand there are no guarantees and that you're risking the money you can afford to lose.If your child's going off to university in a couple of years and the funds you've allocated for investing will pay his or her tuition, you might want to keep your funds parked in something more stable.As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Tech Stocks That Transformed Their Business * 8 Genomic Testing Stocks That Can Ease the Sting of Theranos * 7 Weak Blue-Chip Stocks to Trim Immediately The post 5 Tips for Making Money in Penny Stocks appeared first on InvestorPlace.

  • PR Newswire

    Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System

    MINNEAPOLIS , Aug. 20, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower ® Control Kit for the ProteinSimple™-branded Maurice platform. This ...